RADIANCY INTRODUCES NEW PSORIASIS LIGHT UNIT ASSEMBLY.

(Full text of statement. Contact details below.)

ORANGEBURG, N.Y., Sept. 30 PRNewswire-AsiaNet - Radiancy, Inc., the global leader in light based skin therapies, has expanded the treatment applications for its LHE(TM) (Light Heat Energy) phototherapy systems by introducing a new light unit assembly (LUA), specially designed to clear mild to moderate psoriasis. The company has already introduced the new LHE application in Asia, Latin America, Europe and Canada, and expects to conduct additional clinical trials in the US at the beginning of 2004 in order to pursue marketing clearance by the US Food & Drug Administration (FDA).

Radiancy's new psoriasis LUA enables LHE phototherapy practitioners to perform a fourth treatment application in addition to vascular and pigmented lesions, acne phototherapy and photoepilation. Like the other LUAs, the modular psoriasis LUA attaches quickly to the Radiancy SkinStation(R), SpaTouch(R) Pro, and Xtreme Clear(TM) LHE phototherapy systems.

In clinical studies to date, LHE phototherapy combined with a salicylic acid regimen has been shown to be safe and effective for the treatment of mild to moderate plaque and guttate psoriasis. Clinical results show an average reduction of 65% in patients' Psoriasis Severity Index (PSI), a standard measure of the erythema, scaling and induration of a psoriasis plaque. Up to 75% clearance of psoriatic lesions has been reported.

According to Dr. Amos Leviav, Kaplan Hospital, Rehovot, Israel, a clinical investigator evaluating LHE in the treatment of psoriasis, "The Light and Heat Energy selective photothermolysis system delivers controlled heat simultaneously with the light pulse, has a large spot size and relieves itching after one week of treatment, making the system very efficient and sufficiently cost-effective to be considered for widespread use."

The LHE technology developed by ...